银屑病关节炎患者-话题@MedSci - 梅斯（MedSci）

#银屑病关节炎患者#

29篇内容 | 1235人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1815038, encodeId=beb918150387f, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=Rheumatol Ther：托法替布对银屑病关节炎患者疼痛减轻的作用, objectType=article, longId=739106, objectId=bfaae3910664, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfaae3910664, replyNumber=0, likeNumber=92, createdTime=2023-02-21, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfaae3910664, moduleTitle=Rheumatol Ther：托法替布对银屑病关节炎患者疼痛减轻的作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bfaae3910664)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815033, encodeId=f271181503308, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=ARD: 用肿瘤坏死因子抑制剂治疗的类风湿关节炎和银屑病关节炎患者的严重感染发生率和发生风险, objectType=article, longId=301418, objectId=fc89301418cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc89301418cc, replyNumber=0, likeNumber=107, createdTime=2022-10-11, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc89301418cc, moduleTitle=ARD: 用肿瘤坏死因子抑制剂治疗的类风湿关节炎和银屑病关节炎患者的严重感染发生率和发生风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fc89301418cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815037, encodeId=5d34181503e65, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=ARD：ixekizumab 在银屑病关节炎患者中的安全性：来自超过2000患者年暴露的四项临床试验的数据, objectType=article, longId=731154, objectId=1e2be3115479, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e2be3115479, replyNumber=0, likeNumber=76, createdTime=2022-11-10, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e2be3115479, moduleTitle=ARD：ixekizumab 在银屑病关节炎患者中的安全性：来自超过2000患者年暴露的四项临床试验的数据, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1e2be3115479)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815034, encodeId=81691815034e9, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=Front Med ：新型预测模型分析新发银屑病关节炎患者的相关并发症研究, objectType=article, longId=727201, objectId=cda9e272018b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cda9e272018b, replyNumber=0, likeNumber=111, createdTime=2022-09-28, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cda9e272018b, moduleTitle=Front Med ：新型预测模型分析新发银屑病关节炎患者的相关并发症研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cda9e272018b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815036, encodeId=db9d181503631, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=ARD：IL-12/23通路抑制剂优特克单抗或TNFi 治疗银屑病关节炎患者的持久性和有效性相当, objectType=article, longId=730741, objectId=13a2e30741f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13a2e30741f5, replyNumber=0, likeNumber=75, createdTime=2023-04-19, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13a2e30741f5, moduleTitle=ARD：IL-12/23通路抑制剂优特克单抗或TNFi 治疗银屑病关节炎患者的持久性和有效性相当, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=13a2e30741f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815030, encodeId=14c91815030fb, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=银屑病关节炎患者该如何自我护理？, objectType=article, longId=276069, objectId=6b0b2e60696f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b0b2e60696f, replyNumber=0, likeNumber=85, createdTime=2022-02-13, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b0b2e60696f, moduleTitle=银屑病关节炎患者该如何自我护理？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6b0b2e60696f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815035, encodeId=3625181503574, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=Dermatology：银屑病关节炎患者的皮肤病比单纯银屑病患者更严重？, objectType=article, longId=728199, objectId=08a0e2819917, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08a0e2819917, replyNumber=0, likeNumber=0, createdTime=2022-06-22, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08a0e2819917, moduleTitle=Dermatology：银屑病关节炎患者的皮肤病比单纯银屑病患者更严重？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=08a0e2819917)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815032, encodeId=01891815032e0, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=英国NICE推荐Rinvoq用于银屑病关节炎患者, objectType=article, longId=294120, objectId=a9742941208a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9742941208a, replyNumber=0, likeNumber=81, createdTime=2022-06-05, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9742941208a, moduleTitle=英国NICE推荐Rinvoq用于银屑病关节炎患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a9742941208a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815031, encodeId=a8bb181503100, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=JAMA Dermatol：银屑病和银屑病关节炎患者的患病率、发病率和癌症发病风险, objectType=article, longId=294002, objectId=fb962940022e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb962940022e, replyNumber=0, likeNumber=90, createdTime=2022-11-22, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb962940022e, moduleTitle=JAMA Dermatol：银屑病和银屑病关节炎患者的患病率、发病率和癌症发病风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fb962940022e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815029, encodeId=0e5b1815029bc, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=Ann Rheum Dis：肿瘤坏死因子抑制剂治疗的类风湿性关节炎和银屑病关节炎患者的严重感染发生情况比较, objectType=article, longId=218374, objectId=8acb2183e4d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8acb2183e4d8, replyNumber=0, likeNumber=75, createdTime=2022-05-07, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8acb2183e4d8, moduleTitle=Ann Rheum Dis：肿瘤坏死因子抑制剂治疗的类风湿性关节炎和银屑病关节炎患者的严重感染发生情况比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8acb2183e4d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815028, encodeId=ddfa181502887, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=ARD:评估Taltz(ixekizumab)与阿达木单抗治疗银屑病关节炎患者的疗效和安全性, objectType=article, longId=216821, objectId=a6d72168217e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6d72168217e, replyNumber=0, likeNumber=104, createdTime=2021-11-25, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6d72168217e, moduleTitle=ARD:评估Taltz(ixekizumab)与阿达木单抗治疗银屑病关节炎患者的疗效和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a6d72168217e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815027, encodeId=6b27181502e1b, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=J INTERN MED：银屑病和银屑病关节炎患者冠状动脉疾病的患病率和严重程度如何？, objectType=article, longId=211227, objectId=13a921122e04, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13a921122e04, replyNumber=0, likeNumber=84, createdTime=2022-01-28, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13a921122e04, moduleTitle=J INTERN MED：银屑病和银屑病关节炎患者冠状动脉疾病的患病率和严重程度如何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=13a921122e04)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815025, encodeId=bdd31815025e7, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=J Rheumatol：银屑病关节炎患者的肝脏异常, objectType=article, longId=192499, objectId=dfc6192499e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfc6192499e8, replyNumber=0, likeNumber=77, createdTime=2021-02-24, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfc6192499e8, moduleTitle=J Rheumatol：银屑病关节炎患者的肝脏异常, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dfc6192499e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815026, encodeId=4829181502686, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=J Rheumatol：银屑病关节炎患者狼疮合并症的患病率高, objectType=article, longId=194378, objectId=56501943e880, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56501943e880, replyNumber=0, likeNumber=0, createdTime=2021-04-30, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56501943e880, moduleTitle=J Rheumatol：银屑病关节炎患者狼疮合并症的患病率高, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=56501943e880)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815024, encodeId=e67618150249f, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=J Rheumatol：银屑病关节炎患者药理生物标志物与治疗反应和长期残疾的关联, objectType=article, longId=185920, objectId=da8518592079, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da8518592079, replyNumber=0, likeNumber=90, createdTime=2020-08-26, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da8518592079, moduleTitle=J Rheumatol：银屑病关节炎患者药理生物标志物与治疗反应和长期残疾的关联, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=da8518592079)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815021, encodeId=5b0d18150213e, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=J Rheumatol：银屑病关节炎患者的负担和疾病特征, objectType=article, longId=161848, objectId=97161618482f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97161618482f, replyNumber=0, likeNumber=101, createdTime=2019-10-03, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97161618482f, moduleTitle=J Rheumatol：银屑病关节炎患者的负担和疾病特征, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=97161618482f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815022, encodeId=113218150226b, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=Ann Rheum Dis：银屑病关节炎患者关节和皮肤改善对健康相关生存质量的影响, objectType=article, longId=166670, objectId=67e51666e060, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67e51666e060, replyNumber=0, likeNumber=112, createdTime=2019-10-04, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67e51666e060, moduleTitle=Ann Rheum Dis：银屑病关节炎患者关节和皮肤改善对健康相关生存质量的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=67e51666e060)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815023, encodeId=c9c4181502327, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=Ann Rheum Dis：银屑病关节炎患者关节手术的发生率和时间趋势, objectType=article, longId=175937, objectId=08d31e593712, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08d31e593712, replyNumber=0, likeNumber=71, createdTime=2020-05-14, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08d31e593712, moduleTitle=Ann Rheum Dis：银屑病关节炎患者关节手术的发生率和时间趋势, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=08d31e593712)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815018, encodeId=dabc181501849, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=J Rheumatol：银屑病关节炎患者矫形外科手术的发生率和预测因素, objectType=article, longId=148078, objectId=b8c21480e88d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8c21480e88d, replyNumber=0, likeNumber=86, createdTime=2019-02-10, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8c21480e88d, moduleTitle=J Rheumatol：银屑病关节炎患者矫形外科手术的发生率和预测因素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b8c21480e88d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1815019, encodeId=13c218150193f, content=<a href='/topic/show?id=f0959663657' target=_blank style='color:#2F92EE;'>#银屑病关节炎患者#</a>, objectTitle=J Rheumatol：妊娠对银屑病关节炎患者疾病活动性的影响, objectType=article, longId=149135, objectId=09f614913587, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09f614913587, replyNumber=0, likeNumber=96, createdTime=2018-10-14, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09f614913587, moduleTitle=J Rheumatol：妊娠对银屑病关节炎患者疾病活动性的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=09f614913587)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

银屑病关节炎患者

2020-05-29

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

Rheumatol Ther：托法替布对银屑病关节炎患者疼痛减轻的作用

2023-02-21

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

ARD: 用肿瘤坏死因子抑制剂治疗的类风湿关节炎和银屑病关节炎患者的严重感染发生率和发生风险

2022-10-11

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

ARD：ixekizumab 在银屑病关节炎患者中的安全性：来自超过2000患者年暴露的四项临床试验的数据

2022-11-10

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

Front Med ：新型预测模型分析新发银屑病关节炎患者的相关并发症研究

2022-09-28

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

ARD：IL-12/23通路抑制剂优特克单抗或TNFi 治疗银屑病关节炎患者的持久性和有效性相当

2023-04-19

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

银屑病关节炎患者该如何自我护理？

2022-02-13

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

Dermatology：银屑病关节炎患者的皮肤病比单纯银屑病患者更严重？

2022-06-22

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

英国NICE推荐Rinvoq用于银屑病关节炎患者

2022-06-05

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

JAMA Dermatol：银屑病和银屑病关节炎患者的患病率、发病率和癌症发病风险

2022-11-22

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

Ann Rheum Dis：肿瘤坏死因子抑制剂治疗的类风湿性关节炎和银屑病关节炎患者的严重感染发生情况比较

2022-05-07

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

ARD:评估Taltz(ixekizumab)与阿达木单抗治疗银屑病关节炎患者的疗效和安全性

2021-11-25

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

J INTERN MED：银屑病和银屑病关节炎患者冠状动脉疾病的患病率和严重程度如何？

2022-01-28

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

J Rheumatol：银屑病关节炎患者的肝脏异常

2021-02-24

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

J Rheumatol：银屑病关节炎患者狼疮合并症的患病率高

2021-04-30

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

J Rheumatol：银屑病关节炎患者药理生物标志物与治疗反应和长期残疾的关联

2020-08-26

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

J Rheumatol：银屑病关节炎患者的负担和疾病特征

2019-10-03

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

Ann Rheum Dis：银屑病关节炎患者关节和皮肤改善对健康相关生存质量的影响

2019-10-04

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

Ann Rheum Dis：银屑病关节炎患者关节手术的发生率和时间趋势

2020-05-14

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

J Rheumatol：银屑病关节炎患者矫形外科手术的发生率和预测因素

2019-02-10

xue8602 (审核中...)

前往app查看评论内容

#银屑病关节炎患者#

J Rheumatol：妊娠对银屑病关节炎患者疾病活动性的影响

2018-10-14

科室
- - 订阅+
  - 更多科室
工具
服务